Other
Alcohol
0
Pipeline Programs↗
13
Active Trials↗
9
Companies Involved↗
Alcohol is an early-stage landscape with 0 programs across 9 companies. The most active players are Johnson & Johnson, BlackThorn Therapeutics, Inc., Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
97
clinical trials
Completed63 · 65%
Recruiting10 · 10%
Terminated9 · 9%
Unknown status6 · 6%
Withdrawn5 · 5%
Suspended1 · 1%
Other3 · 3%
Clinical Trials
Trial Activity
97 trials
Probenecid Administration for Alcohol Craving and Consumption
Recruiting·—·Phase 2·NCT07118618·120 enrolled
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
Recruiting·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 1·NCT06819189·50 enrolled
Suvorexant and Alcohol
Recruiting·—·Phase 1·NCT06326684·30 enrolled
Behavioral Alcohol Responses (BAR) Study
Active, not recruiting·—·Phase 1·NCT03467191·782 enrolled
Effects of Ghrelin on Alcohol Cue Reactivity and Craving
Completed·—·N/A·NCT01190085·45 enrolled
Page 1 of 7
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)